#United States #Corona #K-Beauty #CTK #OTC manufacturing

CTK Expands K-beauty Reach with New OTC Facility in California

In December 2025, CTK, a leading original design manufacturer (ODM) for cosmetics based in South Korea, proudly announced the opening of its new facility, CTK OTC Laboratories, in Corona, California. This strategic move marks CTK’s commitment to tapping into the growing North American market, particularly in the realm of K-beauty, which now stands as one of the world's largest cosmetics markets.

CTK acquired the 40,000-square-foot manufacturing plant and accompanying 30,000-square-foot logistics warehouse in March 2025, with the vision to not only manufacture outstanding products but also to serve as a comprehensive partner throughout every stage of product development. From initial planning and production to navigating regulatory compliance and launching products into the market, CTK aims to streamline the entire process, ensuring its client companies can deliver innovative K-beauty products smoothly and efficiently.

Manufacturing Capabilities

The new facility boasts an annual production capacity that exceeds 20 million units and is fully registered with the U.S. Food and Drug Administration (FDA) for over-the-counter (OTC) product manufacturing, meeting rigorous international Good Manufacturing Practices (GMP) standards. With safety and stability as critical components in the production of OTC cosmetics, CTK has established a trusted reputation through its stable formulations and the implementation of a stringent quality control system.

Conveniently located just a 15-minute drive from CTK’s fulfillment center, the OTC facility allows for same-day transfer, storage, and processing of orders once production is completed. The streamlined supply chain can significantly reduce lead times and cut down on distribution fees, which ultimately supports clients in achieving longer sales periods and stronger inventory management.

“In the OTC category, product credibility is paramount,” shares Cheeho Choi, Head of CTK’s U.S. OTC Business. “Through our new facility, we are committed to upholding high-quality standards and providing transparent information, which in turn, helps garner trust from consumers and the broader market alike.”

Quick Response to Market Trends

CTK is dedicated to staying ahead of trends driven by North American consumers by actively updating and reflecting regulatory changes from key global markets in real-time. This adaptability not only enables faster development cycles and production of innovative formulations but also fosters a responsive approach in line with emerging trends in the K-beauty sector.

The officials emphasized the vital role that the new facility will play in establishing a connection to the U.S. West Coast market, thereby serving as a global hub for K-beauty OTC products. Furthermore, CTK plans to create a versatile OTC portfolio including not only skincare products but also functional color cosmetics, with new formulations introduced twice yearly.

Conclusion

As CTK strengthens its foothold in the North American market with this new manufacturing facility, the company envisions facilitating aggressive launch strategies for its clients. By combining a flexible production system with strategic geographic proximity to major U.S. retail channels, CTK is poised to deliver products to the market faster, keep them accessible to consumers longer, and maintain a cost-competitive edge. The California facility embodies CTK’s enduring spirit of innovation, ensuring that the next wave of K-beauty products is ready to meet the demands of its growing consumer base.

For more information about CTK and its offerings, visit CTK's website and CTK OTC Laboratories.